Medizone International, Inc. (OTCBB: MZEI) Blockbuster Potential

Medizone International, Inc. (OTCBB: MZEI) (http://medizoneint.com)

Medizone International, Inc. This is a great time to get in.

Medizone International, Inc. filed an international patent application in early July 2010.   The Asepticsure(TM) technology has effective technology in clearing healthcare and other critical infrastructure of bacterial infections such as C. difficile, MRSA, E coli, Pseudomonas aeruginous and VRE down to complete sterilization standard.

After the international patent application has been searched and examined by the International Patent Office authorities, Medizone can register it in any or all countries of the world that have ratified the PCT (of which there are over 140 such countries, which includes all major industrialized countries), and secure grant of patents on the application in countries of its choice.

This means there are 140 countries in which MZEI can earn revenue.   MRSA is not just an American problem — it is a world problem.  Hospitals everywhere are looking for the solution MZEI brings to the table.

Now is the time to be in MZEI.  Did you read the Chairman’s Message of August 4, 2010 (Link Here):

Relative to government activity, on June 28th I had written, “Due to the sensitivity of some of the subject matter, shareholders should not expect any further information to be forthcoming for some time in this area.” While that statement remains true today, and at this time we are not in a position to offer specifics, I must say that both Dr. Shannon and I, as well as the entire board of directors, could not be more pleased with both the level of interest being shown and supportive steps being initiated from very high levels of government, relative to the potentiality of AsepticSure™ and support for specific development programs.

What we know from covering this Company for a long period of time is that they have a history of understating their potential.

Medizone International, Inc. has a product that is in great demand — if there were a product out there that could address MRSA the CDC would not have confirmed 99,000 deaths in the United States annually from Hospital Acquired Infections.  MZEI brings a solution to the table:  AsepticSure(TM) System which is to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure.

As second use is the government variant which is being developed for bio-terrorism counter measures.

MZEI has the potential to be the blockbuster of the year and that chart is poised for a breakout.

Contact: Medizone International, Inc. (OTCBB: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone: 415-868-0300
Fax: 415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

This release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

Pentony Enterprises LLC is STOCKGURU.COM. 1601 Berwick Drive, McKinney, Texas 75070 – (469) 252-3030.  Disclosure: Pentony Enterprises LLC entered into an investor relations consulting and market awareness contract with Medizone International, Inc.  Pentony Enterprises LLC was previously compensated 500,000 144 restricted common shares by the company for profile coverage for the period ending May 30, 2010.  Currently, Pentony Enterprises LLC as StockGuru has no contract with MZEI.   To avoid all potential conflicts of interest, we never sell shares into the open market during an active market awareness or investor relations program. This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.